Nifty
Sensex
:
:
9217.95
29655.84
98.55(1.08%)
290.54(0.99%)

Chemicals

Rating :
68/99   (View)

BSE: 530019 | NSE: JUBILANT

789.00
-18.45 (-2.28%)
24-Apr-2017 | 1:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 810.00
  • 818.00
  • 766.00
  • 807.45
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  • 402345
  • 3174.50
  • 878.00
  • 285.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 12,862.75
  • 280.30
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 17,034.99
  • 0.37%
  • 6.28

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.02%
  • 3.78%
  • 13.35%
  • FII
  • DII
  • Others
  • 1.81%
  • 3.54%
  • 23.50%

Chart

Price | P:E | P:BV | EV:EBITDA

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 16
Dec 15
Var%
Sep 16
Sep 15
Var%
Jun 16
Jun 15
Var%
Mar 16
Mar 15
Var%
Net Sales
1,458.22
1,379.45
5.71%
1,385.50
1,463.05
-5.30%
1,419.53
1,458.55
-2.68%
1,501.27
1,536.54
-2.30%
Expenses
1,126.40
1,074.44
4.84%
1,045.17
1,142.47
-8.52%
1,051.37
1,132.88
-7.19%
1,183.31
1,295.30
-8.65%
EBITDA
331.82
305.01
8.79%
340.33
320.58
6.16%
368.16
325.67
13.05%
317.96
241.24
31.80%
EBIDTM
22.25%
22.11%
23.98%
21.91%
25.94%
22.33%
21.18%
15.70%
Other Income
5.12
2.85
79.65%
4.92
4.47
10.07%
4.29
3.80
12.89%
2.52
5.83
-56.78%
Interest
98.19
90.01
9.09%
79.96
97.42
-17.92%
82.77
92.65
-10.66%
89.93
79.20
13.55%
Depreciation
72.65
74.65
-2.68%
72.01
75.10
-4.11%
71.52
70.21
1.87%
126.02
66.21
90.33%
PBT
166.48
139.96
18.95%
193.43
154.84
24.92%
218.26
168.55
29.49%
120.99
67.79
78.48%
Tax
47.99
23.03
108.38%
49.72
39.02
27.42%
54.24
40.49
33.96%
50.31
25.06
100.76%
PAT
118.49
116.93
1.33%
143.71
115.82
24.08%
164.02
128.06
28.08%
70.68
42.73
65.41%
PATM
7.94%
8.48%
10.13%
7.92%
11.55%
8.78%
4.71%
2.78%
EPS
7.69
7.34
4.77%
9.31
7.27
28.06%
10.14
8.04
26.12%
4.44
2.68
65.67%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Net Sales
5,802.32
5,826.25
5,803.36
5,165.95
4,303.13
3,445.62
3,791.13
3,517.98
2,488.34
1,808.87
Net Sales Growth
-0.41%
0.39%
12.34%
20.05%
24.89%
-9.11%
7.76%
41.38%
37.56%
 
Cost Of Goods Sold
2,116.20
2,663.02
2,438.46
2,062.85
1,618.87
1,339.68
1,471.11
1,352.42
986.26
830.33
Gross Profit
3,686.13
3,163.23
3,364.90
3,103.10
2,684.26
2,105.95
2,320.02
2,165.57
1,502.08
978.54
GP Margin
63.53%
54.29%
57.98%
60.07%
62.38%
61.12%
61.20%
61.56%
60.36%
54.10%
Total Expenditure
4,513.72
5,124.71
4,782.37
4,097.81
3,412.94
2,880.76
3,111.07
2,834.73
2,034.35
1,546.77
Power & Fuel Cost
366.71
393.04
389.74
356.73
286.89
224.04
220.03
197.91
170.43
130.48
% Of Sales
6.32%
6.75%
6.72%
6.91%
6.67%
6.50%
5.80%
5.63%
6.85%
7.21%
Employee Cost
1,126.73
1,090.28
1,105.17
962.58
836.36
718.54
735.21
648.49
375.71
211.26
% Of Sales
19.42%
18.71%
19.04%
18.63%
19.44%
20.85%
19.39%
18.43%
15.10%
11.68%
Manufacturing Exp.
436.46
432.40
405.14
360.48
329.75
284.66
315.90
293.91
230.80
169.05
% Of Sales
7.52%
7.42%
6.98%
6.98%
7.66%
8.26%
8.33%
8.35%
9.28%
9.35%
General & Admin Exp.
256.56
302.28
264.23
208.35
200.72
195.72
196.68
191.38
137.43
102.35
% Of Sales
4.42%
5.19%
4.55%
4.03%
4.66%
5.68%
5.19%
5.44%
5.52%
5.66%
Selling & Distn. Exp.
189.08
203.98
160.04
123.28
111.85
90.92
125.97
124.22
107.56
91.16
% Of Sales
3.26%
3.50%
2.76%
2.39%
2.60%
2.64%
3.32%
3.53%
4.32%
5.04%
Miscellaneous Exp.
21.98
39.72
19.59
23.53
28.50
27.21
46.18
26.41
26.15
91.16
% Of Sales
0.38%
0.68%
0.34%
0.46%
0.66%
0.79%
1.22%
0.75%
1.05%
0.67%
EBITDA
1,288.60
701.54
1,020.99
1,068.14
890.19
564.86
680.06
683.25
453.99
262.10
EBITDA Margin
22.21%
12.04%
17.59%
20.68%
20.69%
16.39%
17.94%
19.42%
18.24%
14.49%
Other Income
13.64
42.45
19.06
29.87
31.48
17.24
118.09
106.66
144.41
125.95
Interest
389.40
367.61
337.11
310.93
238.23
119.99
155.57
330.09
38.36
30.46
Depreciation
345.98
287.95
281.17
253.79
220.65
180.10
124.68
163.24
103.91
62.29
PBT
566.87
88.43
421.78
533.29
462.79
282.02
517.90
296.58
456.13
295.30
Tax
152.85
80.48
69.64
152.36
68.41
13.37
95.94
26.72
57.28
71.25
Tax Rate
26.16%
199.55%
33.60%
44.66%
59.95%
5.56%
18.52%
9.01%
12.56%
24.13%
PAT
431.49
-57.76
109.04
152.73
14.56
229.72
421.46
283.18
400.50
228.00
PAT before Minority Interest
431.49
-40.16
137.64
188.78
45.69
227.23
421.95
269.86
398.85
224.06
Minority Interest
0.00
-17.60
-28.60
-36.05
-31.13
2.49
-0.49
13.32
1.65
3.94
PAT Margin
7.44%
-0.99%
1.88%
2.96%
0.34%
6.67%
11.12%
8.05%
16.10%
12.60%
PAT Growth
847.04%
-152.97%
-28.61%
948.97%
-93.66%
-45.49%
48.83%
-29.29%
75.66%
 
Unadjusted EPS
27.09
-3.63
6.85
9.59
0.91
14.42
28.56
19.22
27.28
15.62

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Shareholder's Funds
2,909.57
2,453.52
2,626.51
2,476.12
2,257.03
2,172.27
2,201.34
1,542.64
1,256.20
906.13
Share Capital
15.93
15.93
15.45
15.93
15.93
15.93
15.88
14.76
14.62
14.35
Total Reserves
2,893.64
2,437.59
2,611.07
2,460.19
2,241.10
2,156.34
2,185.46
1,527.89
1,241.50
891.76
Non-Current Liabilities
3,522.97
4,036.15
2,184.95
3,004.85
3,224.12
3,048.25
3,365.15
4,056.86
2,238.68
1,788.63
Secured Loans
2,646.48
3,316.29
1,716.67
1,708.74
2,839.47
2,435.91
2,160.79
2,966.30
1,058.59
417.17
Unsecured Loans
397.50
375.00
0.22
760.06
0.45
400.61
1,011.94
975.49
1,049.87
1,235.44
Long Term Provisions
70.46
67.04
219.53
237.96
169.70
39.87
0.00
0.00
0.00
0.00
Current Liabilities
2,514.48
2,129.16
3,894.41
2,778.35
2,212.79
2,269.67
1,220.11
1,130.63
667.91
524.81
Trade Payables
599.64
721.19
718.14
647.13
836.98
517.43
688.83
584.06
306.65
254.59
Other Current Liabilities
977.21
793.31
1,731.20
898.00
499.55
465.94
64.70
88.72
65.14
37.19
Short Term Borrowings
728.19
517.17
1,187.83
1,131.39
767.07
883.03
0.00
0.00
0.00
0.00
Short Term Provisions
209.44
97.49
257.25
101.84
109.18
403.28
466.59
457.85
296.13
233.03
Total Liabilities
8,947.02
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00
6,824.52
6,762.08
4,184.18
3,236.98
Net Block
5,091.40
4,911.33
5,098.78
4,967.46
4,460.18
3,991.05
3,818.89
3,745.00
1,912.42
1,227.90
Gross Block
7,861.87
7,362.10
7,330.63
6,870.15
6,084.09
5,163.28
4,845.26
4,648.26
2,495.91
1,667.15
Accumulated Depreciation
2,770.47
2,450.76
2,231.85
1,902.69
1,623.92
1,172.22
1,026.38
903.26
583.49
439.25
Non Current Assets
6,045.70
5,904.29
5,935.78
5,809.80
5,465.57
4,940.25
4,357.21
4,281.34
2,402.01
1,464.45
Capital Work in Progress
593.56
596.60
472.39
436.89
685.55
666.71
505.63
503.12
484.69
235.69
Non Current Investment
36.11
39.50
33.99
25.61
19.20
32.75
32.70
33.22
4.90
0.87
Long Term Loans & Adv.
293.32
327.17
328.42
379.47
299.86
249.18
0.00
0.00
0.00
0.00
Other Non Current Assets
31.30
29.68
2.21
0.37
0.79
0.55
0.00
0.00
0.00
0.00
Current Assets
2,901.32
2,714.54
2,928.03
2,561.06
2,297.32
2,591.75
2,455.22
2,205.31
1,780.52
1,768.45
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
223.71
238.13
40.73
3.02
Inventories
1,216.06
1,235.33
1,341.42
1,116.18
1,020.22
691.28
690.95
595.61
434.97
353.24
Sundry Debtors
929.73
819.27
805.87
708.54
652.69
520.45
518.61
504.41
425.78
294.81
Cash & Bank
344.48
394.34
479.53
356.05
266.82
1,045.14
503.67
381.66
523.77
874.91
Other Current Assets
411.05
265.59
301.21
380.29
357.59
334.88
518.27
485.49
355.27
242.47
Short Term Loans & Adv.
246.93
144.56
136.04
182.01
256.70
217.50
498.14
444.09
323.54
228.91
Net Current Assets
386.84
585.38
-966.38
-217.29
84.53
322.08
1,235.11
1,074.69
1,112.61
1,243.64
Total Assets
8,947.02
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00
6,824.51
6,762.08
4,184.18
3,236.98

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Cash From Operating Activity
1,092.30
783.26
772.27
969.90
707.17
389.75
709.61
558.06
257.47
190.64
PBT
584.34
40.32
207.28
341.14
114.11
240.59
517.90
296.58
456.13
295.30
Adjustment
702.67
725.84
756.60
752.36
795.44
318.42
189.22
352.94
34.70
7.55
Changes in Working Capital
-146.64
96.40
-110.70
-4.04
-136.91
-84.14
62.58
-55.56
-185.10
-88.62
Cash after chg. in Working capital
1,140.37
862.57
853.18
1,089.46
772.64
474.88
769.70
593.96
305.73
214.23
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-48.07
-79.31
-80.91
-119.56
-65.47
-85.14
-60.57
-41.99
-45.42
-35.57
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-326.45
-343.33
-174.42
-499.72
-594.31
-352.15
-279.75
-2,030.73
-1,139.35
-367.49
Net Fixed Assets
-59.56
1,162.43
-166.96
-286.05
-434.15
-275.33
-128.63
-492.68
-281.91
-251.03
Net Investments
59.43
239.81
-27.56
-18.79
-95.66
5.14
-159.67
-331.27
-102.45
-1,034.27
Others
-326.32
-1,745.57
20.10
-194.88
-64.50
-81.96
8.55
-1,206.78
-754.99
917.81
Cash from Financing Activity
-822.33
-502.69
-414.41
-449.76
-888.82
608.21
-298.02
1,150.66
592.81
962.95
Net Cash Inflow / Outflow
-56.48
-62.76
183.44
20.41
-775.95
645.81
131.84
-322.01
-289.08
786.10
Opening Cash & Equivalents
391.63
473.49
279.65
263.08
1,041.15
498.27
381.66
523.77
874.91
138.96
Closing Cash & Equivalent
339.17
391.63
473.49
279.65
263.08
1,041.15
505.34
375.89
523.82
874.93

Financial Ratios

Consolidated /

Standalone
Description
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Book Value (Rs.)
182.67
154.04
170.07
155.46
141.70
136.38
137.88
85.89
85.81
62.88
ROA
4.91%
-0.46%
1.60%
2.34%
0.60%
3.17%
6.21%
4.93%
10.75%
8.47%
ROE
16.09%
-1.58%
5.39%
7.98%
2.06%
10.42%
24.42%
21.40%
36.99%
25.98%
ROCE
13.27%
5.72%
7.92%
10.19%
5.79%
6.29%
12.74%
14.62%
16.71%
15.89%
Fixed Asset Turnover
0.78
0.81
0.84
0.82
0.78
0.70
0.82
1.02
1.26
1.27
Receivable days
53.68
49.56
46.53
47.00
48.71
53.83
48.18
46.63
50.03
50.97
Inventory Days
75.23
78.58
75.51
73.76
71.07
71.61
60.59
51.66
54.72
62.44
Payable days
52.31
52.17
51.42
45.33
38.70
50.95
58.42
49.77
49.78
50.27
Cash Conversion Cycle
76.60
75.98
70.61
75.42
81.08
74.50
50.34
48.52
54.97
63.14
Total Debt/Equity
1.55
1.95
1.67
1.71
1.69
1.81
1.45
3.11
1.68
1.83
Interest Cover
2.50
1.11
1.61
2.10
1.48
3.01
4.33
1.90
12.89
10.70

News Update


  • Jubilant Life Sciences issues Commercial Paper worth Rs 100 crore
    18th April 2017

    The tenure of the instrument is 63 days and allotted on April 18, 2017

    Read More
  • Jubilant Life Sciences receives ANDA approval for Celecoxib Capsules
    6th April 2017

    This is the first approval that the company has received from the USFDA during the current financial year

    Read More
  • Jubilant Life Sciences’ arm eyeing to acquire speciality pharma business in USA
    21st March 2017

    The proposed acquisition is a niche, profitable speciality pharma business with a strategic fit and is expected to provide competitive edge

    Read More
  • Jubilant Life Sciences issues Commercial Paper worth Rs 40 crore
    28th February 2017

    The tenure of the instrument is 30 days and allotted on February 28, 2017

    Read More
  • Jubilant Life Sciences receives ANDA approval for Itraconazole Capsules
    27th February 2017

    Itraconazole Capsules is the generic version of Sporanox of Janssen Pharmaceuticals, which is used for the treatment of fungal infections

    Read More
  • Jubilant Life to acquire redeemable preference shares of Jubilant Biosys
    8th February 2017

    The company will acquire 18,66,20,000 12% Optionally Convertible Non-cumulative Redeemable Preference Shares of Rs 10 each aggregating to Rs 186.62 crore

    Read More
  • Jubilant Life Sciences reports marginal fall in Q3 consolidated net profit
    7th February 2017

    Total income of the company increased by 6.65% at Rs 1496.76 crore for the quarter under review

    Read More
  • Jubilant LifeScience - Quarterly Results
    7th February 2017

    Read More
  • Jubilant Life Sciences raises Rs 495 crore via NCDs
    28th January 2017

    The net proceeds of the issue shall be mainly used for refinancing of existing debt

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.